心力衰竭患者NT-proANP、NT-proBNP和NT-proCNP与肾功能指标的相关性分析

被引：14

作者：

吴超 ^{[1
]}

赵雪燕 ^{[1
]}

袁晋青 ^{[1
]}

杨跃进 ^{[1
]}

机构：

[1] 中国医学科学院北京协和医学院国家心血管病中心阜外医院冠心病中心

来源：

南昌大学学报(医学版) | 2021年 / 61卷 / 02期

关键词：

心力衰竭; 肾功能不全; 氨基末端A型利钠肽; 氨基末端B型利钠肽; 氨基末端C型利钠肽;

D O I：

10.13764/j.cnki.ncdm.2021.02.007

中图分类号：

R541.6 [血液循环衰竭];

学科分类号：

1002 ; 100201 ;

摘要：

目的探讨血肌酐轻度升高或正常心力衰竭（心衰）患者氨基末端A型利钠肽（NT-proANP）、氨基末端B型利钠肽（NT-proBNP）和氨基末端C型利钠肽（NT-proCNP）与肾功能指标(肌酐、尿素氮、肾小球滤过率（eGFR）)的相关性。方法测定112例血肌酐<2 mg·dL-1(176.8μmol·L-1)的心衰患者（心衰组）和44例行冠状动脉造影除外冠心病的正常对照者（对照组）的肾功能指标、血肌酐和尿素氮。心衰组按肾功能指标再分为3个亚组,分析NT-proANP、NT-proBNP、NT-proCNP与肾功能指标的相关性及其影响因素。结果与对照组相比,心衰组的肌酐、尿素氮、NT-proANP、NT-proBNP、NT-proCNP值均明显升高,而eGFR明显降低（均P<0.05）。相关性分析:心衰患者Log NT-proANP、Log NT-proBNP和Log NT-proCNP分别与肌酐、尿素氮呈正相关（r=0.221～0.528,均P<0.05）;分别与eGFR呈负相关（r=-0.303～-0.369,均P<0.01）。多元回归分析:是否使用利尿剂、尿素氮和NYHA分级为NT-proANP和NT-proBNP的独立影响因素,而肌酐为NT-proCNP的独立影响因素（均P<0.05）。结论肾功能正常或伴有轻度肾功能不全的心衰患者,利钠肽水平与肾功能指标密切相关,对该类患者应关注肾功能指标对利钠肽的影响。

引用

页码：34 / 38 +67

页数：6

共 13 条

[1] Heart failure and kidney dysfunction: epidemiology, mechanisms and management[J] . Schefold Joerg C,Filippatos Gerasimos,Hasenfuss Gerd,Anker Stefan D,von Haehling Stephan. ature reviews. Nephrology . 2016 (10)
[2] Heart Failure With Preserved Ejection Fraction: A Kidney Disorder?[J] . Fang James C. irculation . 2016 (6)
[3] Prognostic value of serial measurements of blood urea nitrogen in ambulatory patients with chronic heart failure
Lombardi, Carlo
Carubelli, Valentina
Rovetta, Riccardo
Castrini, Anna I.
Vizzardi, Enrico
Bondei, Ivano
Sciatti, Edoardo
Manerba, Alessandra
Benlodi, Erika
Nodari, Savina
Metra, Marco
[J]. PANMINERVA MEDICA, 2016, 58 (01) : 8 - 15
[4] Association between renin-angiotensin system antagonist use and mortality in heart failure with severe renal insufficiency: a prospective propensity score-matched cohort study[J] . Edner Magnus,Benson Lina,Dahlstr?m Ulf,Lund Lars H. uropean heart journal . 2015 (34)
[5] Chronic kidney disease and cardiovascular complications
Di Lullo, Luca
House, Andrew
Gorini, Antonio
Santoboni, Alberto
Russo, Domenico
Ronco, Claudio
[J]. HEART FAILURE REVIEWS, 2015, 20 (03) : 259 - 272
[6] MDRD方程在我国慢性肾脏病患者中的改良和评估
全国eGFR课题协作组
[J]. 中华肾脏病杂志, 2006, (10) : 589 - 595
[7] Cardiac biomarkers of heart failure in chronic kidney disease[J] . Xiaorong Han,Shuai Zhang,Zhongbo Chen,Binay Kumar Adhikari,Ying Zhang,Jin Zhang,Jian Sun,Yonggang Wang. linica Chimica Acta . 2020 (prep)
[8] C-Type Natriuretic Peptide: A Multifaceted Paracrine Regulator in the Heart and Vasculature[J] . Amie J. Moyes,Adrian J. Hobbs. nternational Journal of Molecular Sciences . 2019 (9)
[9] Exploring the relation between changes in NT-proBNP and renal function in patients with suspected heart failure using structural equation modelling[J] . Jufen Zhang,Kenneth Y-K. Wong,Andrew L. Clark,John G.F. Cleland. nternational Journal of Cardiology . 2017
[10] Renal impairment and outcomes in heart failure: systematic review and meta-analysis . Smith Grace L,Lichtman Judith H,Bracken Michael B,Shlipak Michael G,Phillips Christopher O,DiCapua Paul,Krumholz Harlan M. Journal of the American College of Cardiology . 2006

← 1 2 →